Rezultaty - Hong Zuo

  • Rezultaty 1 - 3 Rezultaty od 3
Redukuj rezultaty
  1. 1

    Sodium-glucose cotransporter-1 inhibition and depression: A Mendelian randomization study od Gang Fan, Hong Zuo, Xun Shi, Bo Liu

    Wydane 2025-07-01

    Objective: The present study aims to determine the causal association between sodium-glucose cotransporter inhibitors and depression, as previous observational studies have concluded a potential link between sodium-glucose cotransporter 1/2 inhibition and depression. Methods: A total of 16 instrumen...

    Szczegółowa specyfikacja

    Dokumenty pełnotekstowe
    Artykuł
  2. 2

    The Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors for Patients with Anticancer Therapy: A Meta-Analysis of Cohort Studies od Gang Fan, Hong Zuo, Lin Lin, Chao Xu, Rui Yan

    Wydane 2025-06-01

    Background: Chemotherapy-induced cardiotoxicity is the leading cause of non-tumorrelated mortality among patients with tumors. Although sodium glucose cotransporter 2 inhibitors (SGLT2is) have been shown to confer cardiovascular benefits, their effects and safety profile in patients with cancer rema...

    Szczegółowa specyfikacja

    Dokumenty pełnotekstowe
    Artykuł
  3. 3

    A case report of ‘Two-Hit’ digenic mutations in PAH: role of PADN in management od Zai-qiang Zhang, Zai-qiang Zhang, Zhou-qiang Qin, Zhou-qiang Qin, Sheng-kui Zhu, Sheng-kui Zhu, Yu-hong Zuo, Yu-hong Zuo, Jia-wang Ding, Jia-wang Ding

    Wydane 2025-07-01

    BackgroundPulmonary arterial hypertension (PAH) is a severe cardiopulmonary disorder characterized by progressive elevation of pulmonary vascular resistance, resulting to right ventricular dysfunction and premature mortality. Although genetic mutations are increasingly recognized in PAH pathogenesis...

    Szczegółowa specyfikacja

    Dokumenty pełnotekstowe
    Artykuł